Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
The Company has selected and finalized with five clinical sites in Florida, Texas and California for enrollment of patients in the Phase 3..
© 2023 Frontier Merchant Capital Group. All Rights Reserved.